The long term objective of the proposed research is to understand how genes are switched on and off in response to specific signals. The human interferon-beta gene (IFN-beta) will be used as a model system to approach this problem.
The specific aims of the project will be to characterize the structure and function of the multicomponent transcriptional enhancer complex of the IFN-beta gene (the IFN-beta enhanceosome), to investigate the role of chromosomal context and global chromatin structure in the regulation of IFN-beta gene expression, and to characterize a new family of IkappaB kinases. Structural studies will include the application of nuclear magnetic resonance and X-ray crystallography to determine the structure of specific components of the enhanceosome; and single particle visualization of the enhanceosome by atomic force microscopy and electron microscopy. The role of chromosome context and global chromatin structure will be approached by identifying and characterizing long range regulatory sequences within the IFN gene cluster. Comparative genomic sequence information and chromatin accessibility studies will be used to identify putative regulatory sequences. The functional importance of these sequences will then be examined by introducing large regions of the gene cluster on bacterial artificial chromosomes (BACs) into cells in culture. Putative regulatory sequences will be deleted or altered and the consequences on IFN gene expression determined. Finally, with respect to the new family of IkappaB kinases, studies will be carried out to determine their role in the activation of NF-kappaB in different cell types and to identify and clone both upstream and downstream kinases. If successful, these studies will provide significant new insights into the mechanisms of gene regulation and signal transduction, both of which are of fundamental importance in the understanding and treatment of human diseases.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Research Project (R01)
Project #
5R01AI020642-22
Application #
6832847
Study Section
Cell Development and Function Integrated Review Group (CDF)
Program Officer
Goodrich, Adrienne J
Project Start
1983-12-01
Project End
2006-12-31
Budget Start
2005-01-01
Budget End
2005-12-31
Support Year
22
Fiscal Year
2005
Total Cost
$501,950
Indirect Cost
Name
Harvard University
Department
Microbiology/Immun/Virology
Type
Schools of Arts and Sciences
DUNS #
082359691
City
Cambridge
State
MA
Country
United States
Zip Code
02138
Zhao, Mingwei; Zhang, Jiangwen; Phatnani, Hemali et al. (2012) Stochastic expression of the interferon-? gene. PLoS Biol 10:e1001249
Ng, Sze-Ling; Friedman, Brad A; Schmid, Sonja et al. (2011) I?B kinase epsilon (IKK(epsilon)) regulates the balance between type I and type II interferon responses. Proc Natl Acad Sci U S A 108:21170-5
Ye, Junqiang; Chen, Shuibing; Maniatis, Tom (2011) Cardiac glycosides are potent inhibitors of interferon-? gene expression. Nat Chem Biol 7:25-33
Ye, Junqiang; Maniatis, Tom (2011) A prion-like trigger of antiviral signaling. Cell 146:348-50
Ye, Junqiang; Maniatis, Tom (2011) Negative regulation of interferon-ýý gene expression during acute and persistent virus infections. PLoS One 6:e20681
Huang, Hon-Ren; Chen, Zhijian J; Kunes, Sam et al. (2010) Endocytic pathway is required for Drosophila Toll innate immune signaling. Proc Natl Acad Sci U S A 107:8322-7
Falvo, James V; Lin, Charles H; Tsytsykova, Alla V et al. (2008) A dimer-specific function of the transcription factor NFATp. Proc Natl Acad Sci U S A 105:19637-42
Panne, Daniel; Maniatis, Tom; Harrison, Stephen C (2007) An atomic model of the interferon-beta enhanceosome. Cell 129:1111-23
McWhirter, Sarah M; Fitzgerald, Katherine A; Rosains, Jacqueline et al. (2004) IFN-regulatory factor 3-dependent gene expression is defective in Tbk1-deficient mouse embryonic fibroblasts. Proc Natl Acad Sci U S A 101:233-8
Yang, Hongmei; Lin, Charles H; Ma, Gang et al. (2003) Interferon regulatory factor-7 synergizes with other transcription factors through multiple interactions with p300/CBP coactivators. J Biol Chem 278:15495-504

Showing the most recent 10 out of 42 publications